Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million.
DGAP-News: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Half Year Report European Healthcare Acquisition & Growth Company B.V. publishes its Half Year Report for the
/PRNewswire/ Isleworth Healthcare Acquisition Corp. (the "Company") (Nasdaq: ISLE; ISLEW) today announced that it has cancelled its special meeting of.
Isleworth Healthcare Acquisition Corp Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Isleworth Healthcare Acquisition Corp Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.